CORT
Corcept Therapeutics Inc
Pharmaceuticals
Corcept Therapeutics Inc (CORT) Insider Trading
33 transactions reported on SEC Form 4 — executive and director buys and sells.
Buys
0
Sells
11
Net value
$-9.1M
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Maduck Sean | See Remarks | Sell | 413 | $47.7K | 9d ago |
| Maduck Sean | See Remarks | Exercise | 24,587 | $203.3K | 8d ago |
| Maduck Sean | See Remarks | Sell | 15,843 | $1.8M | 8d ago |
| Gunn Justin Frederick | See Remarks | Grant | 100,000 | — | 9d ago |
| Lyon Joseph Douglas | See Remarks | Sell | 4,446 | $514.4K | 8d ago |
| Maduck Sean | See Remarks | Exercise | 413 | $3.4K | 9d ago |
| Vieira Roberto Wandenkolk | President, Oncology | Exercise | 8,333 | $180.2K | 8d ago |
| Vieira Roberto Wandenkolk | President, Oncology | Sell | 1,100 | $126.0K | 8d ago |
| Lyon Joseph Douglas | See Remarks | Exercise | 810 | $11.0K | 9d ago |
| Lyon Joseph Douglas | See Remarks | Sell | 810 | $93.5K | 9d ago |
| Lyon Joseph Douglas | See Remarks | Exercise | 3,357 | $45.5K | 8d ago |
| Robb Gary Charles | Chief Business Officer | Exercise | 17,493 | $144.7K | 23d ago |
| Vieira Roberto Wandenkolk | President, Oncology | Sell | 296 | $29.8K | 24d ago |
| Lyon Joseph Douglas | See Remarks | Grant | 130 | $14.7K | Sep 1, 2026 |
| Lyon Joseph Douglas | See Remarks | Tax | 72 | $8.2K | Sep 2, 2026 |
| Vieira Roberto Wandenkolk | President, Oncology | Exercise | 58,333 | $1.3M | Sep 2, 2026 |
| Guyer William | Chief Development Officer | Grant | 164 | $18.6K | Sep 1, 2026 |
| Maduck Sean | See Remarks | Exercise | 25,000 | $206.8K | Sep 1, 2026 |
| Maduck Sean | See Remarks | Sell | 11,730 | $1.3M | Sep 1, 2026 |
| Maduck Sean | See Remarks | Grant | 150 | $17.0K | Sep 1, 2026 |
| Maduck Sean | See Remarks | Tax | 117 | $13.3K | Sep 2, 2026 |
| Mokari Atabak | Chief Financial Officer | Grant | 138 | $15.6K | Sep 1, 2026 |
| Mokari Atabak | Chief Financial Officer | Tax | 102 | $11.6K | Sep 2, 2026 |
| Robb Gary Charles | Chief Business Officer | Grant | 164 | $18.6K | Sep 1, 2026 |
| Robb Gary Charles | Chief Business Officer | Tax | 91 | $10.3K | Sep 2, 2026 |
| Vieira Roberto Wandenkolk | President, Oncology | Grant | 138 | $15.6K | Sep 1, 2026 |
| Vieira Roberto Wandenkolk | President, Oncology | Tax | 102 | $11.6K | Sep 2, 2026 |
| Vieira Roberto Wandenkolk | President, Oncology | Sell | 23,600 | $2.6M | Sep 2, 2026 |
| Mokari Atabak | Chief Financial Officer | Sell | 7,919 | $687.2K | Jul 15, 2026 |
| Mokari Atabak | Chief Financial Officer | Exercise | 15,833 | $304.9K | Jul 15, 2026 |
| WILSON JAMES N | Sell | 1,079 | $93.6K | Jul 15, 2026 | |
| Guyer William | Chief Development Officer | Exercise | 20,000 | $433.0K | Jul 7, 2026 |
| Guyer William | Chief Development Officer | Sell | 19,048 | $1.8M | Jul 7, 2026 |